Be cautious with: Crash diets and very low-calorie plans Aggressive fasting if you are not supervised Highly restrictive plans that cut major food groups without a medical reason If you have diabetes, kidney disease, or take insulin/sulfonylureas, get clinician input before big changes
This personalized insight helps you and your provider understand whether your body responds optimally to semaglutide alone or whether additional compounds or lifestyle modifications suit your genetic profile
Semaglutide products include Novo Nordisks Wegovy, the first weight loss drug approved by the FDA to minimize heart risks, and Ozempic
document HbA1c target and achieved level Symptomatic pain management: pregabalin, gabapentin, duloxetine (FDA-approved for DPN), TCAs Foot care: preventive podiatry, custom diabetic footwear (HCPCS A5500A5513), monofilament testing Cardiovascular autonomic: fludrocortisone, midodrine for orthostatic hypotension
When IDO-1 is activated, it negatively impacts cellular energy metabolism by catalyzing the conversion of tryptophan into kynurenine, leading to tryptophan depletion
